Ezetimibe + simvastatin versus doubling the dose of simvastatin in high cardiovascular risk diabetics: a multicenter, randomized trial (the LEAD study)

BACKGROUND: The primary goal of therapy in patients with hypercholesterolemia and coronary heart disease (CHD) is reducing low-density lipoprotein cholesterol (LDL-C). This was a multicenter, randomized, double-blind, double-dummy study in patients with type 2 diabetes mellitus (T2DM). METHODS: Adul...

Descripción completa

Detalles Bibliográficos
Autores principales: Bardini, Gianluca, Giorda, Carlo B, Pontiroli, Antonio E, Le Grazie, Cristina, Rotella, Carlo M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Original investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2887787/
https://www.ncbi.nlm.nih.gov/pubmed/20492655
http://dx.doi.org/10.1186/1475-2840-9-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2887787/
https://www.ncbi.nlm.nih.gov/pubmed/20492655
http://dx.doi.org/10.1186/1475-2840-9-20

Ejemplares similares